Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02531087 · ClinicalTrials.gov registry record

Urinary Biomarkers of OI Pathobiology

A clinical trial of Osteogenesis Imperfecta, sponsored by Baylor College of Medicine.

Active
Registry status
25
Enrollment target
7
Study locations

NCT02531087 is a study of Osteogenesis Imperfecta that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 25 participants, below the 159-participant average among 13 other Osteogenesis Imperfecta trials with a reported enrollment target (84% lower). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02531087, a study of Osteogenesis Imperfecta, is active but no longer recruiting, sponsored by Baylor College of Medicine.

ACTIVE NOT RECRUITING
Registry status
25 participants
Enrollment target
7
Study locations

Study Summary

Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss, dental problems, pain and difficulty getting around. Before the genetic cause of OI was known, OI was classified into four types. Each type was based upon the symptoms and severity of OI. In most people with OI, the cause is a change in one of the genes that makes a protein called type 1 collagen. Some doctors now classify OI both on how severe it is as well as which gene is causing OI. When people classify OI this way, there are more than 10 types of OI. The current laboratory testing to determine OI subtype involves the collection of blood and/or skin cells.

Conditions Studied

Osteogenesis Imperfecta

Study Locations (7)

California

  • University of California Los Angeles - Los Angeles

Nebraska

  • University of Nebraska Medical Center - Omaha

New York

  • Hospital for Special Surgery - New York

Oregon

  • Oregon Health Science University - Portland

Texas

  • Baylor College of Medicine - Houston

Wisconsin

  • Shriners Hospital for Children - Milwauke

Quebec

  • Shriners Hospital for Children - Montreal

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2015-08-17
Est. Completion 2026-08-31

Sponsor

Baylor College of Medicine

616 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02531087

The ClinicalTrials.gov registry entry for NCT02531087 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 159-participant average among 13 other Osteogenesis Imperfecta trials with a reported enrollment target (84% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteogenesis Imperfecta appearing as the primary indexed condition, and to 0 interventions.

NCT02531087 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Nebraska, New York.

Frequently Asked Questions

What is clinical trial NCT02531087 about?

NCT02531087 is a clinical study titled "Urinary Biomarkers of OI Pathobiology". Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may have other problems, including hearing loss, dental problems, pain and difficulty getting around. Before the genetic cause of OI was known, ...

What is the current status of trial NCT02531087?

This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2015-08-17. Estimated completion is 2026-08-31.

What conditions does trial NCT02531087 study?

This clinical trial studies the following conditions: Osteogenesis Imperfecta.

Who is sponsoring clinical trial NCT02531087?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02531087 being conducted?

This trial has 7 study locations across California, Nebraska, New York, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Osteogenesis Imperfecta

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Osteogenesis Imperfecta

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.